Japanese Patent Office issues patent for ZIOPHARM Oncology's darinaparsin

[News]

ZIOPHARM Oncology, Inc. today announced that the Japanese Patent Office has issued a patent, Patent No. 4,571,408, with claims covering pharmaceutical compositions, including oral formulations, of various organic arsenic compounds, including darinaparsin (Zinapar or ZIO-101), and the use of these compositions and the organic arsenic compounds for the treatment of cancer, including as part of a combination therapy.

More... (http://www.news-medical.net/news/20100928/Japanese-Patent-Office-issues-patent-for-ZIOPHARM-Oncologys-darinaparsin.aspx)